These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6317277)

  • 1. Single-dose plasma and cerebrospinal fluid pharmacokinetics of ceftriaxone in infants and children.
    Reed MD; Rekate HL; Aronoff SC; Myers CM; Blumer JL
    Clin Pharm; 1983; 2(6):558-63. PubMed ID: 6317277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetics of ceftriaxone in blood and ventricular cerebrospinal fluid in children with ventriculitis].
    Prado V; Arancibia A; Aguirre X
    Bol Med Hosp Infant Mex; 1984 Jun; 41(6):313-7. PubMed ID: 6089848
    [No Abstract]   [Full Text] [Related]  

  • 3. Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment.
    Kanegaye JT; Soliemanzadeh P; Bradley JS
    Pediatrics; 2001 Nov; 108(5):1169-74. PubMed ID: 11694698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of antimicrobial drugs in the cerebrospinal fluid.
    Skopnik H; Heimann G
    Pediatr Pharmacol (New York); 1983; 3(3-4):313-20. PubMed ID: 6330656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children.
    Goldwater PN
    Int J Antimicrob Agents; 2005 Nov; 26(5):408-11. PubMed ID: 16216469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial meningitis in children in southern Ghana.
    Commey JO; Rodrigues OP; Akita FA; Newman M
    East Afr Med J; 1994 Feb; 71(2):113-7. PubMed ID: 7925039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic profile of ceftriaxone in man.
    Patel IH; Kaplan SA
    Am J Med; 1984 Oct; 77(4C):17-25. PubMed ID: 6093513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed cerebrospinal fluid sterilization and adverse outcome of bacterial meningitis in infants and children.
    Lebel MH; McCracken GH
    Pediatrics; 1989 Feb; 83(2):161-7. PubMed ID: 2913547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftriaxone therapy of meningitis and serious infections.
    Steele RW
    Am J Med; 1984 Oct; 77(4C):50-3. PubMed ID: 6093519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of ceftriaxone in neonates and infants with meningitis.
    Martin E; Koup JR; Paravicini U; Stoeckel K
    J Pediatr; 1984 Sep; 105(3):475-81. PubMed ID: 6088747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability of ceftriaxone pharmacokinetics in hospitalized patients with severe infections.
    Joos B; Luethy R; Muehlen E; Siegenthaler W
    Am J Med; 1984 Oct; 77(4C):59-62. PubMed ID: 6093521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective comparative trial of ceftriaxone vs. conventional therapy for treatment of bacterial meningitis in children.
    Barson WJ; Miller MA; Brady MT; Powell DA
    Pediatr Infect Dis; 1985; 4(4):362-8. PubMed ID: 3895175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A single daily injection of ceftriaxone for treating suppurated meningitis in infants and children. Apropos of 31 cases].
    Floret D; Melki I; Janin N; Reverdy E
    Pediatrie; 1987; 42(3):199-204. PubMed ID: 3658622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis.
    Del Rio M; McCracken GH; Nelson JD; Chrane D; Shelton S
    Antimicrob Agents Chemother; 1982 Oct; 22(4):622-7. PubMed ID: 6295262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early vancomycin therapy and adverse outcomes in children with pneumococcal meningitis.
    Buckingham SC; McCullers JA; Luján-Zilbermann J; Knapp KM; Orman KL; English BK
    Pediatrics; 2006 May; 117(5):1688-94. PubMed ID: 16651325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of ceftriaxone in pediatric patients with meningitis.
    Steele RW; Eyre LB; Bradsher RW; Weinfeld RE; Patel IH; Spicehandler J
    Antimicrob Agents Chemother; 1983 Feb; 23(2):191-4. PubMed ID: 6301362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftriaxone therapy of bacterial meningitis: cerebrospinal fluid concentrations and bactericidal activity after intramuscular injection in children treated with dexamethasone.
    Bradley JS; Farhat C; Stamboulian D; Branchini OG; Debbag R; Compogiannis LS
    Pediatr Infect Dis J; 1994 Aug; 13(8):724-8. PubMed ID: 7970973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology and cerebrospinal fluid penetration of moxalactam in children and dosage recommendations.
    Kaplan SL; Mason EO; Kvernland SJ; Calaway EL; Feigin RD
    Rev Infect Dis; 1982; 4 Suppl():S597-602. PubMed ID: 6218570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cefotaxime monotherapy in bacterial meningitis in childhood].
    Helwig H; Schlegel P
    Monatsschr Kinderheilkd; 1986 Oct; 134(10):733-7. PubMed ID: 3796634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose ceftriaxone pharmacokinetics in pediatric patients with central nervous system infections.
    Chadwick EG; Yogev R; Shulman ST; Weinfeld RE; Patel IH
    J Pediatr; 1983 Jan; 102(1):134-7. PubMed ID: 6294263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.